基础医学与临床 ›› 2019, Vol. 39 ›› Issue (2): 197-202.

• 研究论文 • 上一篇    下一篇

TRPV4激动剂4α-PDD减轻大鼠脑缺血/再灌损伤

刘改玲1,都爱莲2,梁辉1   

  1. 1. 浙江省杭州市 浙江大学医学院附属第一医院
    2. 上海市同仁医院
  • 收稿日期:2018-07-02 修回日期:2018-09-28 出版日期:2019-02-05 发布日期:2019-01-16
  • 通讯作者: 梁辉 E-mail:wen1937@suhu.com
  • 基金资助:
    上海市长宁区科学技术委员会基金

TRPV4 agonist 4α-PDD alleviates cerebral ischemia/reperfusion injury in rats

  • Received:2018-07-02 Revised:2018-09-28 Online:2019-02-05 Published:2019-01-16

摘要: 目的 研究内皮瞬时受体电位香草酸亚型4(TRPV4)对大鼠脑缺血/再灌损伤的保护作用及其机制。方法 将30只SD大鼠随机分成sham组和大脑中动脉闭塞(MCAO)组和4α-PDD干预组。MCAO 3h,再灌注72h。采用TTC方法检测脑梗死体积、Garcia评分评估神经损伤程度和定量RT-PCR检测内皮型一氧化氮合酶(eNOS)、血管内皮生长因子受体-2(VEGFA-2)和血管内皮生长因子A(VEGFA)mRNA表达;免疫组化检测CD3和Sox2蛋白表达。结果与sham组相比,MCAO组大鼠脑梗死体积及神经功能缺损明显增加(p < 0.001)。4α-PDD可使MCAO后大鼠脑梗死体积显著缩小(p < 0.001),并改善神经功能缺损(p < 0.05)。4α-PDD显著增加缺血半影区eNOS、VEGFA和VEGFA-2 mRNA表达(p < 0.001)和使缺血半影区内微血管密度显著增加(p < 0.001),而且神经祖细胞(NPC)在缺血半影区增殖和迁移均增加。结论4α-PDD可能通过促进大鼠缺血半影区血管和神经再生改善MCAO后神经功能损伤。

Abstract: Objective To tested whether the endothelial transient receptor potential cation channel subfamily V member 4 (TRPV4) activation could improve functional recovery in rats subjected to brain ischemia/reperfusion and its mechanisms. Methods 30 SD rats were randomly divided into Sham group, middle cerebral artery occlusion(MCAO)group and 4α-PDD group. The volume of cerebral infarction was detected by TTC method;the degree of nerve injury was evaluated by Garcia score; the expression of endothelial nitric oxide synthase (eNOS), VEGF receptor -2 (VEGFA-2) and vascular endothelial growth factor A (VEGFA) mRNA were detected by quantitative RT-PCR; CD3 and Sox2 proteins were detected by immunohistochemistry. Results Compared with Sham group, the volume of cerebral infarction and neurological deficit in MCAO group increased significantly (P < 0.001). 4α-PDD reduced infarct volume (p < 0.001) and improved functional outcomes (p < 0.05) on day 3 after MCAO.TRPV4 activation significantly increased endothelial nitric oxide synthase(eNOS) expression in the ischemic region(p < 0.001). The expressions of vascular endothelial growth factor A (VEGFA) and VEGF receptor-2 were significantly higher in the 4α-PDD group(p < 0.001). 4α-PDD treatment also caused a significantly increase of microvessel density (p < 0.001). In addition, Neural progenitor cells (NPC) proliferation and migration in the ischemic hemisphere were increased, respectively. Conclusion TRPV4 activation by 4α-PDD may improve functional recovery through angiogenesis and neurogenesis after MCAO.